LONDON, ONTARIO--(CCNMatthews - Nov. 7, 2005) - Stellar Pharmaceuticals Inc., (TSX VENTURE:SLX)(OTCBB:SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced that it plans to release its 2005 third quarter financial results prior to the opening of the stock market on Thursday, November 10, 2005. Management will conduct a conference call later that morning at 10:00 a.m. Eastern Time to discuss these results. Interested parties may participate in the call by dialing 888-789-0150 (in the United States) or 416-695-6622 (in Canada) approximately 10 minutes before the call is scheduled to begin and ask to be connected to the Stellar Pharmaceuticals Conference Call. A recorded replay of the call will be available until 11:59 pm Eastern Time on Thursday, November 17, 2005. Listeners may dial 888-509-0081 (in the United States) or 416-695-5275 (in Canada) for the replay.
